Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

New insights in skin conditions show a complex link between certain moles and melanoma, improved hair loss treatments, and the need to identify different types of lupus.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

European dermatologic treatments focus on lifestyle and psychosocial factors, use diverse methods like baths and climate therapy, and emphasize the importance of diet and supplements for skin health.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Mice with enhanced regeneration abilities may help develop new regenerative medicine therapies.

Cyclosporine may cause hair loss, so patients need monitoring.

Hair changes can indicate systemic diseases or medication effects.

An 80-year-old man grew extra hair on his forearms after starting Alzheimer's medication rivastigmine.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Light affects skin health, aging, and cancer risk, and new light-based treatments and imaging are promising for skin care.

Gabapentin may cause hair loss in patients treated for neuropathic pain.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.